D03.9 Melanoma in situ, unspecified
D03.9 is a risk-adjusting diagnosis under CMS-HCC and RxHCC models. Create a free account to see model versions, RAF contribution, and AI-powered HCC suppression analysis.
Get what a quick lookup can't: the AI assistant for official-guideline questions, HCC risk-adjustment mappings (CMS-HCC V24/V28, RxHCC), FDA drug indications, and AHA Coding Clinic references for D03.9.
The ICD-10-CM code for Melanoma in situ, unspecified is D03.9 (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Chapter
- 2: Neoplasms (C00-D49)
- Section
- D00-D09: In situ neoplasms (D00-D09)
- Category D03
- 32 codes (23 billable)
- FY2026 Status
- Stable since FY2024
Also Known As
ICD-10-CM Alphabetic Index entries that lead to D03.9:
- Melanoma (malignant) › in situ
- Melanoma (malignant) › in situ › nail
U.S. Hospital Utilization
- An estimated 245 U.S. inpatient stays in 2023 included D03.9 among the documented diagnoses.
Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.
Official Coding Guidelines
Tx of primary site (TOC entry)a. Admission/Encounter for treatment of primary site ............................................................. 33
Tx of secondary site (TOC entry)b. Admission/Encounter for treatment of secondary site .......................................................... 33
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026
References
Cite This Page
Reference D03.9 with the canonical source and edition:
D03.9 — Melanoma in situ, unspecified. ICD-10 Coding Pro (ICD-10-CM FY2026). https://icd10codingpro.com/codes/D03.9
Canonical URL: https://icd10codingpro.com/codes/D03.9